Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹6,821 Cr₹5,897 Cr₹4,221 Cr₹3,675 Cr₹3,290 Cr
Adjustment ₹518 Cr₹641 Cr₹878 Cr₹967 Cr₹1,131 Cr
Changes In working Capital ₹-665 Cr₹-806 Cr₹-559 Cr₹-177 Cr₹372 Cr
Cash Flow after changes in Working Capital ₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr₹4,793 Cr
Cash Flow from Operating Activities ₹5,005 Cr₹4,134 Cr₹3,238 Cr₹3,326 Cr₹3,755 Cr
Cash Flow from Investing Activities ₹-3,691 Cr₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr₹-2,387 Cr
Cash Flow from Financing Activities ₹-1,293 Cr₹-1,200 Cr₹-958 Cr₹-1,600 Cr₹-1,240 Cr
Net Cash Inflow / Outflow ₹21 Cr₹-55 Cr₹-109 Cr₹-146 Cr₹129 Cr
Opening Cash & Cash Equivalents ₹512 Cr₹561 Cr₹658 Cr₹790 Cr₹649 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹9.26 Cr₹5.56 Cr₹12 Cr₹13 Cr₹13 Cr
Closing Cash & Cash Equivalent ₹543 Cr₹512 Cr₹561 Cr₹658 Cr₹790 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹127,264.9 Cr 1.8% 1.9% -5.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics
MANKIND PHARMA ₹109,835.0 Cr 3% 6.2% 7.5% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

1.8%

1.9%

-5.6%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses